Use of ergot derivative lisuride in Parkinson's disease.
D000328:Adult; D000368:Aged; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008090:Lisuride / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D004873:Ergolines; D008090:Lisuride